Handelsbanken Fonder
NVAX icon

Handelsbanken Fonder’s Novavax NVAX Stock Holding History

Handelsbanken Fonder’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-25,100
Closed -$174K – 1613
2023
Q1 		$174K Hold
25,100
– – ﹤0.01% 1477
2022
Q4 		$258K Buy
25,100
+12,900
+106% +$228K ﹤0.01% 1327
2022
Q3 		$222K Hold
12,200
– – ﹤0.01% 1401
2022
Q2 		$627K Buy
12,200
+1,400
+13% +$72.5K ﹤0.01% 897
2022
Q1 		$795K Sell
10,800
-1,500
-12% -$134K ﹤0.01% 894
2021
Q4 		$1.76M Sell
12,300
-500
-4% -$85.9K 0.01% 657
2021
Q3 		$2.65M Buy
12,800
+600
+5% +$132K 0.01% 567
2021
Q2 		$2.59M Buy
12,200
+900
+8% +$165K 0.01% 586
2021
Q1 		$2.05M Hold
11,300
– – 0.01% 602
2020
Q4 		$1.26M Buy
+11,300
New +$1.2M 0.01% 730

Other funds holding NVAX

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Shah Capital Management Raleigh, North Carolina $521M AUM 46.95% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Handelsbanken Fonder's NVAX Position: Q2 2023 in Review

Handelsbanken Fonder sold out of Novavax (NVAX) in Q2 2023, closing a stake of 25,100 shares — an estimated $174K sold.

Handelsbanken Fonder first reported a position in NVAX in Q4 2020 and held it in 10 quarters. The position peaked at $2.65M in Q3 2021. 216 funds tracked by Wall St. Rank hold NVAX as of Q2 2023.

  • Handelsbanken Fonder reported no remaining Novavax position as of Q2 2023 after selling out during the quarter.
  • Handelsbanken Fonder sold 25,100 Novavax shares in Q2 2023, an estimated $174K.
  • Handelsbanken Fonder first reported a position in Novavax in Q4 2020 and held it in 10 quarters.
  • Handelsbanken Fonder's Novavax position peaked at $2.65M in Q3 2021.
  • 216 funds tracked by Wall St. Rank held Novavax as of Q2 2023.

Based on Handelsbanken Fonder's 13F filing for Q2 2023, filed 2 Aug 2023.